These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 25045773)
1. Global Advisory Committee on Vaccine Safety, 11-12 June 2014. Wkly Epidemiol Rec; 2014 Jul; 89(29):325-35. PubMed ID: 25045773 [No Abstract] [Full Text] [Related]
2. Global Advisory Committee on Vaccine Safety, 3–4 December 2014. Wkly Epidemiol Rec; 2015 Jan; 90(4):17-24. PubMed ID: 25618910 [No Abstract] [Full Text] [Related]
3. Hepatitis E vaccine: WHO position paper, May 2015. Wkly Epidemiol Rec; 2015 May; 90(18):185-200. PubMed ID: 25935931 [No Abstract] [Full Text] [Related]
4. Global Advisory Committee on Vaccine Safety, 6–7 December 2017. Wkly Epidemiol Rec; 2018 Jan; 93(2):17-30. PubMed ID: 29350500 [No Abstract] [Full Text] [Related]
5. Hepatitis E virus: Current epidemiology and vaccine. Wu X; Chen P; Lin H; Hao X; Liang Z Hum Vaccin Immunother; 2016 Oct; 12(10):2603-2610. PubMed ID: 27184971 [TBL] [Abstract][Full Text] [Related]
6. Development of new hepatitis E vaccines. Cao Y; Bing Z; Guan S; Zhang Z; Wang X Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836 [TBL] [Abstract][Full Text] [Related]
7. Meeting of the Strategic Advisory Group of Experts on immunization, October 2014 – conclusions and recommendations. Wkly Epidemiol Rec; 2014 Dec; 89(50):561-76. PubMed ID: 25513671 [No Abstract] [Full Text] [Related]
8. Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009. Wkly Epidemiol Rec; 2009 Aug; 84(32):325-32. PubMed ID: 19860024 [No Abstract] [Full Text] [Related]
11. Meeting of the Global Advisory Committee on Vaccine Safety, 7–8 June 2017. Wkly Epidemiol Rec; 2017 Jul; 92(28):393-402. PubMed ID: 28707463 [No Abstract] [Full Text] [Related]
12. Lessons from hepatitis E vaccine design. Li S; Zhang J; Xia N Curr Opin Virol; 2015 Apr; 11():130-6. PubMed ID: 25913817 [TBL] [Abstract][Full Text] [Related]
13. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. Zaman K; Dudman S; Stene-Johansen K; Qadri F; Yunus M; Sandbu S; Gurley ES; Overbo J; Julin CH; Dembinski JL; Nahar Q; Rahman A; Bhuiyan TR; Rahman M; Haque W; Khan J; Aziz A; Khanam M; Streatfield PK; Clemens JD BMJ Open; 2020 Jan; 10(1):e033702. PubMed ID: 31959609 [TBL] [Abstract][Full Text] [Related]
14. Global Advisory Committee on Vaccine Safety, 12-13 June 2007. Wkly Epidemiol Rec; 2007 Jul; 82(28-29):252-9. PubMed ID: 17642098 [No Abstract] [Full Text] [Related]
15. Perspectives of vaccination against hepatitis E. Safary A Intervirology; 2001; 44(2-3):162-6. PubMed ID: 11509877 [TBL] [Abstract][Full Text] [Related]
16. Global Advisory Committee on Vaccine Safety, 10-11 June 2015. Wkly Epidemiol Rec; 2015 Jul; 90(29):365-72. PubMed ID: 26189216 [No Abstract] [Full Text] [Related]
17. Pfizer’s men B vaccine shows promise in phase 2. Hum Vaccin Immunother; 2012 Aug; 8(8):1016-7. PubMed ID: 23359878 [No Abstract] [Full Text] [Related]
18. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):273. PubMed ID: 20224545 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a recombinant hepatitis E vaccine. Shrestha MP; Scott RM; Joshi DM; Mammen MP; Thapa GB; Thapa N; Myint KS; Fourneau M; Kuschner RA; Shrestha SK; David MP; Seriwatana J; Vaughn DW; Safary A; Endy TP; Innis BL N Engl J Med; 2007 Mar; 356(9):895-903. PubMed ID: 17329696 [TBL] [Abstract][Full Text] [Related]
20. Global Advisory Committee on Vaccine Safety, 1-2 December 2005. Wkly Epidemiol Rec; 2006 Jan; 81(2):15-9. PubMed ID: 16671243 [No Abstract] [Full Text] [Related] [Next] [New Search]